{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:37:19Z","timestamp":1792831039093,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1903101"],"award-info":[{"award-number":["U1903101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M783584"],"award-info":[{"award-number":["2025M783584"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","award":["XY2025062"],"award-info":[{"award-number":["XY2025062"]}],"id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioorg.2026.110654","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:09:44Z","timestamp":1791846584000},"page":"110654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and structure-activity relationship studies of marine-derived indolocarbazoles as potent PIM1 inhibitors for triple-negative breast cancer therapy"],"prefix":"10.1016","volume":"183","author":[{"given":"Yun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiebin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Churu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110654_bb0005","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/cac2.12207","article-title":"Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020","volume":"41","author":"Lei","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bioorg.2026.110654_bb0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-022-01260-0","article-title":"Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies","volume":"15","author":"Liao","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.110654_bb0015","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12967-022-03462-z","article-title":"Inhibition of autophagy by chloroquine prevents resistance to PI3K\/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models","volume":"20","author":"Cocco","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioorg.2026.110654_bb0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-021-01930-w","article-title":"Efficacy and mechanism of the combination of PARP and CDK4\/6 inhibitors in the treatment of triple-negative breast cancer","volume":"40","author":"Zhu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110654_bb0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41422-020-0375-9","article-title":"Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the future trial","volume":"31","author":"Jiang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.bioorg.2026.110654_bb0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","article-title":"Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies","volume":"35","author":"Jiang","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2026.110654_bb0035","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/nm.4198","article-title":"PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer","volume":"22","author":"Bras\u00f3-Maristany","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.110654_bb0040","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm.4213","article-title":"PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression","volume":"22","author":"Horiuchi","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.110654_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107454","article-title":"Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer","volume":"207","author":"Malone","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2026.110654_bb0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jcmgh.2022.09.014","article-title":"PIM1-induced cytoplasmic expression of RBMY mediates hepatocellular carcinoma metastasis","volume":"15","author":"Chua","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioorg.2026.110654_bb0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.chembiol.2023.10.023","article-title":"PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer","volume":"31","author":"Torres-Ayuso","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110654_bb0060","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1016\/j.apsb.2022.07.005","article-title":"Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo","volume":"12","author":"Yin","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2026.110654_bb0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12964-024-01898-y","article-title":"PIM1 kinase and its diverse substrate in solid tumors","volume":"22","author":"Choudhury","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bioorg.2026.110654_bb0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/acs.jmedchem.3c01802","article-title":"Comprehensive insights that targeting PIM for cancer therapy: prospects and obstacles","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110654_bb0075","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1038\/bcj.2015.46","article-title":"Targeting the Pim kinases in multiple myeloma","volume":"5","author":"Keane","year":"2015","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bioorg.2026.110654_bb0080","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1021\/acs.jnatprod.7b01058","article-title":"Bioactive indolocarbazoles from the marine-derived Streptomyces sp. DT-A61","volume":"81","author":"Wang","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110654_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bioorg.2018.09.016","article-title":"Bioactive staurosporine derivatives from the Streptomyces sp. NB-A13","volume":"82","author":"Zhou","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110654_bb0090","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.tet.2017.12.048","article-title":"Cytotoxic indolocarbazoles alkaloids from the Streptomyces sp. A65","volume":"74","author":"Zhou","year":"2018","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.110654_bb0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.phytol.2017.11.002","article-title":"Bioactive metabolites from marine-derived Streptomyces sp. A68 and its rifampicin resistant mutant strain R-M1","volume":"23","author":"Qin","year":"2018","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.bioorg.2026.110654_bb0100","doi-asserted-by":"crossref","first-page":"12978","DOI":"10.1021\/acs.jmedchem.0c01271","article-title":"Identification, structure-activity relationships of marine-derived indolocarbazoles, and a dual PKC\u03b8\/\u03b4 inhibitor with potent antipancreatic cancer efficacy","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110654_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/13543776.2024.2446224","article-title":"Strategies for the treatment of acute myeloid leukemia with FLT3 mutations: a patent review","volume":"35","author":"Gorecki","year":"2025","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2026.110654_bb0110","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1038\/celldisc.2016.30","article-title":"NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K-AKT and JAK-STAT3 pathways","volume":"2","author":"Yuzugullu","year":"2016","journal-title":"Cell Discov."},{"key":"10.1016\/j.bioorg.2026.110654_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canlet.2016.03.041","article-title":"PKC\u03b5 inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K\/Akt, MAPK\/ERK signaling in renal cell carcinoma cell line 769P","volume":"376","author":"Huang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.110654_bb0120","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1200\/JCO.21.01849","article-title":"Superior efficacy of midostaurin over cladribine in advanced systemic mastocytosis: a registry-based analysis","volume":"40","author":"L\u00fcbke","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110654_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115181","article-title":"Discovery of unglycosylated indolocarbazoles as ROCK2 isoform-selective inhibitors for the treatment of breast cancer metastasis","volume":"250","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110654_bb0130","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/blood-2006-04-015487","article-title":"The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts: the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cases","volume":"108","author":"Knapper","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2026.110654_bb0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1614359","article-title":"Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation","volume":"377","author":"Stone","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.110654_bb0140","doi-asserted-by":"crossref","first-page":"15012","DOI":"10.1021\/acs.jmedchem.4c00577","article-title":"Selective degradation of MLK3 by a novel CEP1347-VHL-02 PROTAC compound limits the oncogenic potential of TNBC","volume":"67","author":"Karpi\u0144ska","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110654_bb0145","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1158\/1078-0432.CCR-05-1859","article-title":"Antitumor efficacy of edotecarin as a single agent and in combination with chemotherapy agents in a xenograft model","volume":"12","author":"Ciomei","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110654_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/biology12081047","article-title":"Protein kinase C at the crossroad of mutations, cancer, targeted therapy and immune response","volume":"12","author":"Aquino","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.bioorg.2026.110654_bb0155","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1074\/jbc.M413155200","article-title":"Pim-1 ligand-bound structures reveal the mechanism of serine\/threonine kinase inhibition by LY294002","volume":"280","author":"Jacobs","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110654_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41568-020-00310-4","article-title":"Equivocal, explicit and emergent actions of PKC isoforms in cancer","volume":"21","author":"Parker","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110654_bb0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11060-015-2020-x","article-title":"A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas","volume":"127","author":"Odia","year":"2016","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.bioorg.2026.110654_bb0170","doi-asserted-by":"crossref","unstructured":"W. Wick, V.K. Puduvalli, M.C. Chamberlain, M.J.v.d. Bent, A.F. Carpentier, L.M. Cher, W. Mason, M. Weller, S. Hong, L. Musib, A.M. Liepa, D.E. Thornton, H.A. Fine, Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma. J. Clin. Oncol. 28 (2010) 1168\u20131174.","DOI":"10.1200\/JCO.2009.23.2595"},{"key":"10.1016\/j.bioorg.2026.110654_bb0175","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1021\/acs.jcim.5c01017","article-title":"DGMM: a deep learning-genetic algorithm framework for efficient lead optimization in drug discovery","volume":"65","author":"Fang","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110654_bb0180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1517\/13543784.2012.668527","article-title":"PIM1 kinase as a target for cancer therapy","volume":"21","author":"Merkel","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bioorg.2026.110654_bb0185","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1084\/jem.20111102","article-title":"Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma","volume":"208","author":"Li","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioorg.2026.110654_bb0190","doi-asserted-by":"crossref","unstructured":"M. Quintero, D. Adamoski, L.M.d. Reis, C.F.R. Ascen\u00e7\u00e3o, K.R.S.D. Oliveira, K.D.A. Gon\u00e7alves, M.M. Dias, M.F. Carazzolle, S.M.G. Dias, Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer. BMC Cancer 17 (2017) 727.","DOI":"10.1186\/s12885-017-3726-2"},{"key":"10.1016\/j.bioorg.2026.110654_bb0195","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1021\/jm5009902","article-title":"Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells","volume":"57","author":"Andreoli","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110654_bb0200","doi-asserted-by":"crossref","first-page":"eadg2253","DOI":"10.1126\/science.adg2253","article-title":"PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection","volume":"382","author":"Fisch","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.110654_bb0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.bioorg.2026.110654_bb0210","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:59:26Z","timestamp":1792828766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826011909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":42,"alternative-id":["S0045206826011909"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110654","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and structure-activity relationship studies of marine-derived indolocarbazoles as potent PIM1 inhibitors for triple-negative breast cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110654"}}